We are dedicated to offering innovative, branded solutions in Women’s and Men’s Health.
Acerus markets ESTRACE® in Canada, a product indicated for the symptomatic relief of menopausal symptoms.
NATESTO®, a product utilizing our licensed nasal gel technology, is the first and only testosterone nasal gel available in Canada and in the United States for replacement therapy in adult males diagnosed with hypogonadism.
GYNOFLOR™, a product licensed to Acerus in Canada by Medinova AG and approved in 39 countries worldwide, is an ultra-low dose vaginal estrogen therapy with the addition of lactobacillus, for the treatment of atrophic vaginitis, certain vaginal infections and/or to restore a healthy vaginal environment.
TEFINA™, a “use as required” testosterone nasal gel, is our drug development candidate aimed at addressing a significant unmet need for women with female sexual dysfunction.
To learn more about each of these novel products, please click the additional pages.